Alimta and Urticaria generalised - a phase IV clinical study of FDA data

Summary:

Urticaria generalised is reported only by a few people who take Alimta.

The phase IV clinical study analyzes which people take Alimta and have Urticaria generalised. It is created by eHealthMe based on reports of 7,644 people who have side effects while taking Alimta from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 23, 2022

7,644 people reported to have side effects when taking Alimta.
Among them, 5 people (0.07%) have Urticaria generalised.


What is Alimta?

Alimta has active ingredients of pemetrexed disodium. eHealthMe is studying from 7,700 Alimta users for its effectiveness, alternative drugs and more.

What is Urticaria generalised?

Urticaria generalised (rash of round, red welts on the skin that itch intensely- generalised) is found to be associated with 523 drugs and 278 conditions by eHealthMe.

Number of Alimta and Urticaria generalised reports submitted per year:

Could Alimta cause Urticaria generalised?

Time on Alimta when people have Urticaria generalised *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Urticaria generalised when taking Alimta *:

  • female: 40 %
  • male: 60 %

Age of people who have Urticaria generalised when taking Alimta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Alimta *:

  1. Folic Acid: 5 people, 100.00%
  2. Zofran: 1 person, 20.00%
  3. Decadron: 1 person, 20.00%
  4. Amaryl: 1 person, 20.00%

Common side effects people have besides Urticaria generalised *:

  1. Skin Hyperpigmentation (disorders affect the colour of your skin): 2 people, 40.00%
  2. Interstitial Lung Disease: 2 people, 40.00%
  3. Skin Exfoliation (removal of the oldest dead skin cells): 1 person, 20.00%
  4. Sinusitis (inflammation of sinus): 1 person, 20.00%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 1 person, 20.00%
  6. Fever: 1 person, 20.00%

Common conditions people have *:

  1. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 80.00%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Alimta and have Urticaria generalised?

Check whether Urticaria generalised is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Urticaria generalised and when was it recovered:

Expand to all the drugs that have ingredients of pemetrexed disodium:

Alternative drugs to, pros and cons of Alimta:

Common Alimta side effects:

Browse all side effects of Alimta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Urticaria generalised treatments and more:

COVID vaccines that are related to Urticaria generalised:

All the drugs that are associated with Urticaria generalised:

All the conditions that are associated with Urticaria generalised:

How the study uses the data?

The study uses data from the FDA. It is based on pemetrexed disodium (the active ingredients of Alimta) and Alimta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: